Showing results (341-350 of 385) with videos related to

Sort By:
Pageof 39
Journal of Viral Hepatitis|February 11, 2019
Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infectionEric Lawitz, Fred Poordad, Leah J Anderson, et al.
The Journal of Infectious Diseases|December 15, 2010
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continentsEftyhia Vardas, Anna R Giuliano, Stephen Goldstone, et al.
The Journal of Infectious Diseases|December 15, 2010
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with menStephen Goldstone, Joel M Palefsky, Anna R Giuliano, et al.
Hepatology (Baltimore, Md.)|July 9, 2017
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failureDavid Wyles, Heiner Wedemeyer, Ziv Ben-Ari, et al.
The New England Journal of Medicine|February 4, 2011
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in malesAnna R Giuliano, Joel M Palefsky, Stephen Goldstone, et al.
Physical Review Letters|May 2, 2015
Identification of the predicted 5s-4f level crossing optical lines with applications to metrology and searches for the variation of fundamental constantsA Windberger, J R Crespo López-Urrutia, H Bekker, et al.
Lancet (London, England)|December 4, 2014
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trialEric Lawitz, Edward Gane, Brian Pearlman, et al.
The Lancet. HIV|October 2, 2015
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trialJürgen K Rockstroh, Mark Nelson, Christine Katlama, et al.
Plos One|February 8, 2019
Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomographyEyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Plos One|January 16, 2019
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomographyEyal Shteyer, Louis Shekhtman, Tal Zinger, et al.
Pageof 39